Previous Article | Next Article 
Infection and Immunity, June 2000, p. 3158-3163, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
SspA Is Required for Lethal Salmonella
enterica Serovar Typhimurium Infections in Calves but Is Not
Essential for Diarrhea
Renée M.
Tsolis,1
L. Garry
Adams,1
Michael J.
Hantman,2
Christina A.
Scherer,2
Tyler
Kimbrough,2
Robert A.
Kingsley,3
Thomas A.
Ficht,1
Samuel I.
Miller,2 and
Andreas
J.
Bäumler3,*
Department of Veterinary Pathobiology,
College of Veterinary Medicine, Texas A&M University, College Station,
Texas 77843-44671; Departments of
Medicine and Microbiology, University of Washington, Seattle,
Washington 981952; and Department of
Medical Microbiology and Immunology, College of Medicine, Texas A&M
University Health Science Center, College Station, Texas
77843-11143
Received 3 November 1999/Returned for modification 24 January
2000/Accepted 25 February 2000
 |
ABSTRACT |
Salmonella pathogenicity island 1 (SPI-1) encodes
virulence determinants, which are important for enteropathogenicity in
calves. To determine whether the Salmonella enterica
serovar Typhimurium SPI-1 effector proteins SspA and SptP are important
for enteropathogenicity, strains lacking these proteins were tested
during oral infection of calves. Calves infected with a
sptP mutant or its isogenic parent developed diarrhea and
lethal morbidity. In contrast, calves infected with an sspA
mutant developed diarrhea, which resolved within 10 days but did not
result in mortality. The sspA mutant was recovered from
bovine intestinal tissues at numbers similar to those obtained for its
isogenic parent and caused marked intestinal lesions. Thus, the
severity of pathological changes caused by serovar Typhimurium strains
or their ability to cause diarrhea were not predictive of their ability
to cause lethal morbidity in calves. We conclude that factors other
than or in addition to bacterial colonization, intestinal lesions, or
electrolyte loss contribute to lethal morbidity in calves infected with
serovar Typhimurium.
 |
INTRODUCTION |
The incidence of human salmonellosis
is estimated to range between 800,000 and 3,700,000 cases per year in
the United States (7). Each year, approximately 40,000 cases
are serotyped and reported to the Centers for Disease Control and
Prevention (6). The incidence of reported
Salmonella infections in the United States is highest among
children aged less than 1 year, with 111 cases per 100,000 population
(5). Between 21 and 38% of human salmonellosis cases in
North America and Europe are due to infection with a single serovar,
Salmonella enterica serovar Typhimurium (4, 20,
37). Serovar Typhimurium infections in humans commonly remain
localized to the intestine and draining lymph nodes and manifest within
48 h after ingestion of contaminated food or water with nausea,
vomiting, and acute diarrhea which progresses toward dysentery
(30). Since serovar Typhimurium usually causes a
self-limited infection with diarrhea resolving within 10 days,
replacement of fluids and electrolytes is the primary approach to
treatment (23). Serovar Typhimurium produces bacteremia in
1.1% of patients (37), and in these cases antibiotic
therapy can be lifesaving. The testing of S. typhimurium
isolates for antibiotic sensitivity has shown that in recent years, an
increasing proportion is resistant to multiple antimicrobial agents
(14). The continuing epidemic of multidrug-resistant serovar
Typhimurium will likely reduce the efficacy of antibiotic therapy in
the future. In order to devise alternate strategies for the control of
salmonellosis, it will be necessary to develop a better understanding
of the fundamental factors that serovar Typhimurium uses to cause
morbidity and mortality.
In addition to its association with human disease, serovar Typhimurium
is a major cause of calf morbidity and mortality in the United States
and in Europe (29, 32). A survey performed in Britain
revealed that Salmonella serovars are associated with 12%
of diarrhea outbreaks among calves (28). Two serotypes, Typhimurium and Dublin, are associated with more than 95% of the salmonellosis cases reported from cattle (13, 34, 35). Since bovine enteritis closely resembles the illness produced by serovar Typhimurium in humans, recent studies have focused on experimental oral
infection of calves to establish an animal model for diarrheal disease
in humans (38, 40). Approximately 75% of serovar
Typhimurium infections occur in calves less than 2 months of age,
before the animals are weaned (34). Calves inoculated orally
with serovar Typhimurium develop diarrhea within 48 h
(27), while the infection remains primarily enteric, with
only occasional bacteremia (43). Oral inoculation of calves
at a dose of 105 to 107 organisms usually
results in a transient diarrhea which resolves within 10 days, but oral
inoculation at higher doses may lead to mortality (33, 43).
Lethal signs of disease in calves include anorexia and central nervous
system depression (33). At necropsy, calves infected with a
lethal dose of serovar Typhimurium present with marked intestinal
lesions. These include acute fibrinopurulent necrotizing enteritis with
pseudomembrane deposition at the luminal surface of the terminal 5 m of the ileum and the cranial 1 to 2 m of the colon. Furthermore,
serovar Typhimurium infection results in lymphoid depletion in germinal
centers of intestinal lymphoid follicles and in the mesenteric lymph
node (38, 43). Although severe intestinal lesions, acute
diarrhea, and the resulting dehydration are striking features of bovine
enteritis, it is not clear whether these signs of disease contribute to
mortality in calves.
Several studies have implicated the invasion-associated type III
secretion system encoded by Salmonella pathogenicity island 1 (SPI-1) in causing diarrhea and mortality in cattle. For instance, mutations in prgH, hilA, and invH,
three genes located on SPI-1, result in strongly reduced diarrhea and
marked attenuation of serovar Typhimurium during oral infection of
calves (38, 40). Furthermore, SPI-1 mutants of serovars
Dublin and Typhimurium elicit reduced fluid accumulation and neutrophil
influx in bovine ligated ileal loops (1, 12). However, the
mechanisms by which SPI-1 promotes enteropathogenicity are unknown.
The main function of the type III secretion system encoded by SPI-1 is
to translocate bacterial effector proteins into the cytosol of the host
cell. Some of the effector proteins translocated by the invasion
associated type III secretion system are encoded by genes that are not
located on SPI-1. For example SopB (also known as SigD), a protein with
inositol phosphate phosphatase activity, is translocated into
epithelial cells by an SPI-1-dependent pathway (12, 24). The
sopB gene is located on SPI-5, and mutational inactivation
results in a modest reduction of fluid secretion elicited by serovar
Dublin in bovine ligated ileal loops (12, 41). However,
unlike strains carrying a mutation in hilA or prgH, a serovar Typhimurium sopB mutant causes
severe diarrhea and mortality at wild-type levels during oral infection
of calves (38). These data suggest that in addition to SopB,
other SPI-1-secreted effector proteins play a role in enteropathogenicity.
Genes located on SPI-1 encode eight secreted targets of the
invasion-associated type III export apparatus, including InvJ (SpaN),
SpaO, AvrA, SptP, SspA (SipA), SspB (SipB), SspC (SipC), and SspD
(SipD) (9-11, 15, 17-19). Five of these targets, AvrA, SptP, SspA, SspB, and SspC, are translocated into epithelial cells and
may thus be considered secreted effector proteins (8, 9, 15,
44). The SspB protein has two functions. It is an effector protein which, after injection into macrophages, causes apoptosis by
binding to caspase-1 (16). In addition, SspB is part of a translocation apparatus (formed by SspB, SspC, and SspD) which is
required for the delivery of secreted effector proteins (e.g., SptP,
AvrA, SopB, SopE, SspB, and SspC) into the eukaryotic cytoplasm (8, 11, 12, 15, 42). Inactivation of sspB results
in a dramatic reduction in fluid secretion and polymorphonuclear cell
influx elicited by serovar Dublin in bovine ligated ileal loops
(12). However, since a mutation in sspB prevents
translocation of a number of targets of the invasion-associated type
III secretion system, it is not clear which secreted effector proteins
are responsible for this phenotype. Furthermore, it is not apparent
from results obtained using the ligated ileal loop assay how a mutation
may effect other aspects of disease, including the severity of
intestinal lesions or lethality (38). To determine the role
of individual SPI-1-secreted effector proteins in producing
virulence-associated phenotypes, such as diarrhea, intestinal lesions,
or lethality, we have investigated the effect of mutations in
sspA and sptP on enteropathogenicity during oral
infection of serovar Typhimurium in calves.
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
Derivatives of ATCC
strain 14028, a bovine serovar Typhimurium isolate, are listed in Table
1. Strain IR715 is a spontaneous nalidixic acid-resistant derivative of 14028 (36). Strain
CS401 is a spontaneous streptomycin-resistant (Strr)
derivative of 14028 which carries a
phoN::Tn10d(Cm) insertion (26). Bacteria were cultured aerobically at 37°C in
Luria-Bertani (LB) broth (per liter, 10 g of tryptone, 5 g of
yeast extract, and 10 g of NaCl) or on LB agar (16 g/liter)
plates. If appropriate, antibiotics were added at the following
concentrations: kanamycin, 100 mg/liter; chloramphenicol, 30 mg/liter;
ampicillin, 100 mg/liter; streptomycin, 100 mg/liter; nalidixic acid,
50 mg/liter.
Construction of mutants.
A nonpolar deletion of the
prgHIJK operon was constructed by allelic exchange. DNA
fragments of approximately 1 kb originating upstream and downstream of
prgH and prgK, respectively, were amplified by
PCR. The fragment upstream of the deletion contained the first 15 nucleotides of prgH, while the downstream fragment contained the last 192 nucleotides of prgK. The upper and lower
flanking regions were ligated together in plasmid pKAS32, a
pir-dependent suicide vector encoding resistance to
ampicillin and an rpsL allele conferring streptomycin
sensitivity (32), to generate pTK62. Plasmid pTK62 was
introduced into Escherichia coli strain
Sm10
pir and transferred into Salmonella
serovar Typhimurium strain CS401 by conjugation. Exconjugants
containing pTK62 integrated into the serovar Typhimurium chromosome
were selected on LB agar plates supplemented with ampicillin and
chloramphenicol. Deletion of the rpsL allele of plasmid
pTK62 by a second recombination event was selected for by plating
exconjugants on LB agar plates containing streptomycin. An
Strr isolate (TK091) containing the prgHIJK
deletion was identified by Southern blot analysis using a 4,307-bp DNA
probe containing the prgHIJK operon. Using the above
strategy, a nonpolar deletion of sptP was constructed by
digesting a cloned 5.5-kb BamHI DNA fragment containing
sptP with EcoRV and AflII. Religation
of the plasmid resulted in a 1,737-bp deletion which removed sequences 247 bp upstream of the sptP start codon to 50 bp downstream
of the codon for the conserved active-site cysteine of SptP. Following integration of a suicide vector containing the 1,736-bp deletion and
streptomycin treatment, an ampicillin-sensitive Strr
isolate (MJH2362) was analyzed by Southern hybridization using the
5.5-kb BamHI fragment as a probe. Nonpolar deletions of
sspB and sspD were constructed using the same
strategy. Regions approximately 1 kb directly upstream and downstream
of the coding sequences of each gene were PCR amplified. The upper and
lower flanking regions were ligated together in pKAS32 to generate
pMM02 (sspB deletion vector) and pMM04 (sspD
deletion vector). These plasmid were introduced into CS401 by
conjugative transfer, and exconjugants were selected for by growth on
LB agar plates containing ampicillin and chloramphenicol. Deletion of
plasmid sequences was induced by growth on LB agar plates supplemented
with streptomycin, and clones containing the deletions were identified
by Southern blot analysis using a DNA probe specific to
sspC. The resultant clones contained a complete deletion of
the sspB coding sequence (CAS152) and a deletion of the
sspD coding sequence through the HindIII site
at nucleotide 1013 (CAS153). The lack of SspB and SspD expression was
confirmed by Western blot analysis (data not shown) with
trichloroacetic acid precipitates of culture supernatants and whole
cell lysates of bacterial cultures (grown to an optical density at 600 nm of 1.2 to 1.5), using antibodies generated to secreted proteins as described previously (17).
Animal experiments.
Milk-fed male Friesian/Holstein calves,
aged 3 to 4 weeks, were obtained from a commercial dairy calf rearing
operation. The weight of the calves ranged between 45 and 52 kg.
Animals were cared for according to Association for Assessment and
Accreditation of Laboratory Animal Care guidelines. Calves were fed 2 liters of milk replacer twice daily and were given water ad libitum. Before being used for experiments, calves were screened for elevated white blood cell counts, fever, and infection with
Salmonella serovars. Salmonella serovars were
detected in fecal swabs by enrichment in tetrathionate broth (Difco)
and plating on brilliant green agar (BBL).
Oral infection of bull calves was performed as described previously
(22). In brief, the optical density of overnight cultures at
600 nm was determined to estimate the number of bacteria per milliliter. A volume containing the desired numbers of bacteria was
added to 50 ml of a suspension of 5% magnesium trisilicate, 5% sodium
bicarbonate, and 5% magnesium carbonate buffer. The inoculum was added
to 950 ml of milk replacer and fed orally to calves. Serial 10-fold
dilutions of the inoculum were spread on LB plates to determine the
exact number of CFU fed to each animal.
A previous report indicates that in calves which survive a serovar
Typhimurium infection, diarrhea does not persist beyond the day 10 postinfection (27). Calves were hence monitored for 10 days
postinfection and then euthanized. When calves developed anorexia or
were unable to stand, they were euthanized for humane reasons as
described previously (22). Weights and fecal scores (assessment of diarrhea) of calves were recorded daily. Shedding of
serovar Typhimurium was monitored by taking daily rectal swabs, subsequent enrichment in tetrathionate broth (Difco), and plating on
brilliant green agar (BBL). Blood samples were taken before (two
samples taken on different days) and at 1 and 2 days after infection.
Determination of concentrations of sodium, chloride, glucose, blood
urea nitrogen, creatinine, aspartate transaminase, alkaline
phosphatase, creatinine kinase, phosphorus, albumen, anion gap, total
calcium, total protein, and total bilirubin in plasma samples was
performed by Clinical Pathology Ektachem (Texas Veterinary Medical
Center, Texas A&M University). The normal range of blood values was
determined from 56 blood samples taken prior to infection from 28 calves (two blood samples were taken from each calf on two separate days).
During competitive infection experiments, groups of four calves were
inoculated at a total dose of approximately 109 CFU/animal
with a 1:1 mixture of wild-type and mutant bacteria. At 4 days
postinfection, animals were euthanized. Tissues were collected,
homogenized in phosphate-buffered saline, and plated in the presence of
the appropriate antibiotics for enumeration of mutant and wild-type
bacteria to determine the output ratio. Data were normalized by
dividing the wild type/mutant output ratio of by the wild type/mutant
input ratio. All data were converted logarithmically prior to the
calculation of averages and statistical analysis. Student's
t test was used to determine whether the wild type/mutant
ratio recovered from infected organs was significantly different from
the wild type/mutant ratio present in the inoculum.
To evaluate the effect of fluid and electrolyte replacement, four
calves were each infected with approximately 1010 CFU of
serovar Typhimurium strain IR715. Two calves were given 1 liter of
rehydration solution (90 mM sodium, 20 mM potassium, 80 mM chloride, 30 mM bicarbonate, 111 mM glucose) intragastrically through a feeding tube
three times daily. Blood values were taken prior to infection and on
days 1 and 2 postinfection. The experiment was repeated with four
calves, two of which received oral rehydration therapy.
Histopathology.
Calves infected with approximately
1010 CFU of mutant or wild-type bacteria were euthanized at
identical time points postinfection to allow direct comparison of the
histopathological lesions. Euthanasia and preparation of tissue samples
for histopathology were performed as described previously
(22). At necropsy, tissue samples from Peyer's patches,
ileum, and mesenteric lymph node were collected; a portion was
homogenized in phosphate-buffered saline and plated in the presence of
the appropriate antibiotics for enumeration of bacteria. The remaining
tissue samples were coded for blind examination. Tissue samples were
fixed in 10% formalin, embedded in paraffin, thin sectioned, and
stained with hematoxylin and eosin for histopathological examination.
 |
RESULTS |
Role of SPI-1 effector genes in calf virulence.
Calves
infected with 1010 CFU of strain CS401, a wild-type
derivative marked by insertion of an antibiotic resistance cassette into the phoN gene, had aqueous diarrhea with feces
containing various combinations of blood, fibrin, and mucus. All calves
developed signs of terminal illness (anorexia or inability to stand)
between days 2 and 5 postinfection and were euthanized (Fig.
1). In contrast, mutations which are
known to prevent type III secretion (phoN
prgHIJK) or translocation of effector proteins into host
cells (
sspB,
sspC, or
sspD)
resulted in marked attenuation. Calves infected with 1010
CFU of strain CAS152 (phoN
sspB), CAS108
(phoN
sspC), CAS153 (phoN
sspD), or TK091 (phoN
prgHIJK)
either had only soft feces for 3 to 4 days or normal feces. After 10 days, all calves were healthy. These data confirm previous reports that
mutations in prgH or hilA, which inactivate the
SPI-1-encoded type III secretion system, reduce the severity of
diarrhea and cause marked attenuation during serovar Typhimurium
infection in calves (38). To assess the role in calf
virulence of SPI-1 effector proteins, which are not required for
protein translocation, groups of four animals were infected orally with
1010 CFU of strain MJH2362 (phoN sptP) or EE633
(phoN sspA). In both groups, all calves developed aqueous
diarrhea comparable to that caused by their isogenic parent (CS401).
The sptP mutant (MJH2362) caused lethal morbidity in three
of four infected calves. In calves infected with the sspA
mutant (EE633), the diarrhea resolved within 10 days and all animals
recovered from the infection.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
Enteropathogenicity of serovar Typhimurium SPI-1
mutants. Graphs show the difference in the plasma concentrations of
sodium (top), total calcium (middle), and total bilirubin (bottom)
determined for samples collected 2 days postinfection relative to a
preinfection sample. Each circle represents data from an individual
animal. Open circles indicate plasma values which were within the
normal range of 133 to 143 mM (sodium), 9.1 to 10.6 mg/dl (total
calcium), or 0.2 to 1.0 mg/dl (total bilirubin); closed circles
indicate plasma values outside the normal range. The ability of serovar
Typhimurium strains to cause lethal infection and diarrhea is shown
below.
|
|
To assess the severity of clinical signs of disease quantitatively, we
determined how the composition of blood changes during infection. Blood
was collected from calves before infection and at day 2 after
infection. This time point was chosen because calves infected with
strain CS401 (phoN) developed signs of terminal illness
starting at day 2 postinfection and were euthanized. The sodium
concentration in plasma of animals that developed diarrhea was
decreased at day 2 postinfection and was below the normal range of 133 to 141 mM in 9 out of 12 animals with diarrhea (Fig. 1). The plasma
concentration of sodium did not decrease notably in calves, which did
not develop diarrhea. The decrease in the plasma sodium concentration
in calves infected with strain CS401 (phoN), MJH2362
(phoN sptP), or EE633 (phoN sspA) was likely
caused by electrolyte loss due to intestinal fluid secretion. These
data thus confirmed that calves infected with CS401 (phoN),
MJH2362 (phoN sptP), or EE633 (phoN sspA)
developed diarrhea of similar severity.
The amount of total calcium decreased in calves with diarrhea and was
below the normal range of 9.1 to 10.5 mg/dl at day 2 postinfection in
all animals infected with strain CS401 (phoN), MJH2362
(phoN sptP), or EE633 (phoN sspA) (Fig. 1). In
contrast, the plasma concentration of calcium stayed within the normal
range in all calves that did not develop diarrhea. A decrease in the total calcium concentrations may be the result of a diarrhea-induced loss of plasma proteins, which bind calcium. A decrease in the plasma
protein content in serovar Typhimurium-infected calves with severe
diarrhea has been reported previously (33). Similarly, we
found that the total protein content of plasma tended to decrease in
calves with severe diarrhea but stayed within the normal range of 5.0 to 7.1 g/dl in all calves.
The amount of total bilirubin increased in all calves infected with
strain CS401 (phoN), MJH2362 (phoN sptP), or
EE633 (phoN sspA) and was above the normal range of 0.3 to
1.0 mg/dl in 10 out of 12 animals with diarrhea (Fig. 1). The amount of
total bilirubin remained within the normal range in animals infected with strain CAS152 (phoN
sspB), CAS108
(phoN
sspC), CAS153 (phoN
sspD), or TK091 (phoN
prgHIJK).
The reason for the increase in the concentration of total bilirubin in
animals infected with strain CS401 (phoN), MJH2362
(phoN sptP), or EE633 (phoN sspA) is unclear.
Ability of serovar Typhimurium mutants to colonize bovine
intestinal tissue and cause lesions.
To assess the effect of
mutations in sptP and sspA on invasion of the
intestinal mucosa in calves, each strain was tested for its ability to
compete with serovar Typhimurium strain IR715 (nalidixic acid-resistant
wild type) for colonization of bovine tissues. Groups of four calves
were infected orally with a 1:1 mixture of wild type (IR715) and one
mutant. Four days postinfection, calves were euthanized and organs
(ileum, Peyer's patch, and mesenteric lymph node) were collected. The
resistance marker of the
phoN::Tn10d(Cm) allele was used to
distinguish the CS401 derivatives from the competing wild-type strain
(IR715). A competitive infection of strain CS401(phoN) and
strain IR715 revealed that strain CS401 displayed a modest defect in
competitive colonization (IR715 was recovered in approximately
fivefold-higher numbers than CS401) (Fig.
2). The colonization defect of CS401 may
be due either to its phoN mutation or to the mutation
leading to streptomycin resistance, but this was not further
investigated. Mutations in sptP (MJH2362) or sspA
(EE633) did not further reduce the ability of a phoN mutant to colonize bovine intestinal tissues (Fig. 2). To compare these results with a colonization defect caused by inactivation of the type
III secretion/translocation machinery, competitive infections with
IR715 were performed with strain CAS152 (phoN
sspB), CAS108 (phoN
sspC), or
CAS153 (phoN
sspD). The wild type (IR715) was recovered in approximately 500- to 1,000-fold-higher numbers from bovine Peyer's patches than CAS152, CAS108, or CAS153. This
observation is consistent with a previous report that during
competitive infection experiments, the serovar Typhimurium wild type is
recovered in 500- to 5,000-fold-higher numbers from bovine Peyer's
patches than strains carrying mutations in hilA or
prgH, two genes required for SPI-1 dependent type III
secretion (39). Thus, sspB, sspC, or
sspD, but not sptP or sspA, is
required for colonization of the bovine intestine by serovar
Typhimurium. Furthermore, there was a good correlation between the
ability of a strain to invade the intestinal mucosa (Fig. 2) and its
ability to cause diarrhea in calves (Fig. 1).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Ability of serovar Typhimurium mutants to compete with a
nalidixic acid-resistant wild-type strain (IR715) for colonization of
bovine tissues. For each mutant, competitive infection was studied with
groups of four animals infected with a 1:1 mixture of wild-type (IR715)
and mutant bacteria. The wild type/mutant ratio recovered from organs
of infected calves 4 days postinfection is shown as mean (bars) ± standard deviation. MLN, mesenteric lymph node; PP, ileal Peyer's
patch proximal to cecum; IL, terminal ileum.
|
|
To determine whether attenuation of the sspA mutant is
related to the severity of intestinal lesions caused by this strain, two calves were infected either with CAS152 (phoN sspB),
EE633 (phoN sspA), or their isogenic parent (CS401). One
calf in each group was euthanized at days 1 and 2 postinfection. At
necropsy, gross pathologic examination was performed and tissue samples from Peyer's patches, ileum, and mesenteric lymph node were collected for histopathologic examination. Strains EE633 (phoN sspA)
and its isogenic parent (CS401) produced macroscopically severe acute fibrinopurulent necrotizing enteritis with segmental or continuous pseudomembrane deposition. No gross pathological lesions were detected
in calves infected with CAS152 (phoN
sspB).
Histopathologic analysis revealed severe lymphoid depletion and
confirmed the severe acute fibrinopurulent necrotizing enteritis in
calves infected with EE633 (phoN sspA) or CS401
(phoN) (data not shown). Intestinal lesions were either
negligible or absent in calves infected with CAS152 (phoN
sspB). Thus, the severity of intestinal lesions correlated with the ability of a mutant to colonize bovine intestinal tissues during a competitive infection experiment.
Effect of oral rehydration therapy on mortality in calves infected
with serovar Typhimurium.
To determine whether mortality in calves
could be prevented by oral rehydration, eight calves, each infected
with 1010 CFU of strain IR715 (wild type), were treated
using oral rehydration therapy (four calves) or were not treated (four
calves). The sodium concentration in blood samples collected before and
1 day after infection were determined. All calves infected with IR715
developed lethal signs of disease and were euthanized, regardless of
whether oral rehydration therapy was performed. The observed changes in sodium concentrations of treated or untreated calves overlapped over a
wide range (Fig. 3). Despite an increase
(relative to preinfection values) in sodium concentrations observed in
two of the calves rehydrated orally, these animals developed lethal
signs of disease and were euthanized 1 day postinfection. Thus, oral
rehydration therapy practiced as described above did not reduce
mortality during experimental infection.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of oral rehydration therapy on plasma
concentrations of total calcium (top) and sodium (bottom). Graphs show
the difference in the plasma concentrations determined for samples
collected 1 day postinfection relative to a preinfection sample. Each
circle represents data from an individual animal. Open circles indicate
plasma values which were within the normal range of 133 to 143 mM
(sodium) or 9.1 to 10.6 mg/dl (total calcium); closed circles indicate
plasma values outside the normal range.
|
|
 |
DISCUSSION |
Serovar Typhimurium requires a functional invasion-associated type
III secretion apparatus to cause diarrhea and mortality in calves. For
instance, mutations in hilA, encoding an activator of SPI-1
genes (2), or prgH, encoding a component of the
type III secretion complex (21, 25), result in marked
attenuation and strongly reduced diarrhea during oral infection of
calves (38). Furthermore, a mutation in sspB
(sipB) causes a dramatic reduction in fluid secretion and
polymorphonuclear cell influx elicited by serovar Dublin in bovine
ligated ileal loops (12). SspB is part of a translocation
complex (formed by SspB, SspC, and SspD) which is required for the
delivery of effector proteins into the eukaryotic cytoplasm (8,
11, 12, 15, 42). Consistent with a role of SPI-1 in
enteropathogenicity, we found that mutations which prevent type III
secretion (prgHIJK) or translocation of effector proteins
into host cells (sspB, sspC, or sspD)
reduced the severity of diarrhea and resulted in marked attenuation of serovar Typhimurium during oral infection of calves (Fig. 1). These
data confirmed that delivery of one or several translocated effector
proteins by the invasion-associated type III secretion system is
required for enteropathogenicity in calves. To assess the contribution
of individual effector proteins encoded by SPI-1 to
enteropathogenicity, we determined the calf virulence of serovar Typhimurium sspA and sptP mutants.
Three of four calves infected with the serovar Typhimurium
sptP mutant and all calves inoculated with its isogenic
parent developed terminal signs of disease and were euthanized. Thus, mutational inactivation of sptP did not result in overt
attenuation. In contrast, all calves inoculated with the serovar
Typhimurium sspA mutant (EE633) survived an infection (Fig.
1). Mutational inactivation of sspA does not result in an
obvious invasion defect in tissue culture cells (17, 18),
although entry is delayed at early time points (44).
Similarly, a mutation in sspA did not result in a
competitive colonization defect for bovine Peyer's patches, ileum, or
mesenteric lymph node (Fig. 2). Furthermore, colonization of bovine
tissues by the sspA mutant resulted in intestinal lesions
similar to those observed in calves infected with its isogenic parent.
Despite its inability to produce lethal morbidity, calves infected with
the sspA mutant developed severe diarrhea. Measurement of
the plasma sodium concentration of infected calves suggested that the
diarrhea-induced electrolyte loss produced by a serovar Typhimurium
sspA mutant was similar to that observed in animals infected
with the isogenic parent (Fig. 1). Significantly, these results suggest
that the loss of fluids and electrolytes may not be the sole cause of
death during bovine enteritis. It has been speculated that mortality in
calves may be caused by massive bacterial growth leading to septicemia
(33), and this possibility cannot be ruled out. We were,
however, unable to detect evidence for endotoxic shock by determining
concentrations of circulating endotoxin in blood samples taken from
moribund calves infected with serovar Typhimurium (data not shown).
SspA is an effector protein which binds and stabilizes actin filaments
and modulates the actin-bundling activity of T-plastin, resulting in a
more pronounced outward extension of serovar Typhimurium-induced membrane ruffles in epithelial cells in vitro (44, 45).
There is currently no obvious connection between this in vitro
observation and the role of SspA in causing lethal morbidity in calves.
Mutational inactivation of sspA does not result in
attenuation of serovar Typhimurium in the mouse typhoid model, in which
diarrhea does not develop (18). Thus, the virulence defect
in calves caused by a mutation in sspA was not predicted by
results obtained using either the mouse or tissue culture model of
serovar Typhimurium infection. These findings illustrate the importance
of using an animal model, which resembles the natural course of
infection and the typical signs of disease, to elucidate serovar
Typhimurium virulence mechanisms important for morbidity and mortality
during diarrheal disease.
 |
ACKNOWLEDGMENTS |
We thank C. Tanksley and T. Parsons for care of animals, R. Barthel and J.-A. Gutiérrez-Pabello for assistance with
necropsies, and R. deLima Santos for critical comments on the manuscript.
Support was provided by USDA/NRICGP grant 9702568 to R.M.T., NRSA
AI09312 to C.A.S., a Poncin fellowship to T.K., PHS grant AI30479 to
S.I.M., USDA Formula Animal Health Funding to T.A.F. and A.J.B.,
USDA/NRICGP grant 9802610 to A.J.B., T.A.F., and L.G.A., and PHS grants
AI40124 and AI44170 to A.J.B.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Microbiology and Immunology, College of Medicine, Texas A&M
University Health Science Center, 407 Reynolds Medical Building,
College Station, TX 77843-1114. Phone: (979) 862-7756. Fax: (979)
845-3479. E-mail: abaumler{at}tamu.edu.
Editor:
A. D. O'Brien
 |
REFERENCES |
| 1.
|
Ahmer, B. M.,
J. van Reeuwijk,
P. R. Watson,
T. S. Wallis, and F. Heffron.
1999.
Salmonella SirA is a global regulator of genes mediating enteropathogenesis.
Mol. Microbiol.
31:971-982[CrossRef][Medline].
|
| 2.
|
Bajaj, V.,
C. Hwang, and C. A. Lee.
1995.
hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes.
Mol. Microbiol.
18:715-727[CrossRef][Medline].
|
| 3.
|
Bajaj, V.,
R. L. Lucas,
C. Hwang, and C. A. Lee.
1996.
Co-odinate regulation of Salmonella typhimurium invasion genes by environmental factors is mediated by control of hilA expression.
Mol. Microbiol.
22:703-714[CrossRef][Medline].
|
| 4.
|
Centers for Disease Control.
1990.
Epidemiologic notes and reports update: Salmonella enteritidis infections and shell eggs United States, 1990.
Morbid. Mortal. Weekly Rep.
39:909-912[Medline].
|
| 5.
|
Centers for Disease Control and Prevention.
1998.
Incidence of foodborne illnesses-FoodNet, 1997.
Morbid. Mortal. Weekly Rep.
47:782-786[Medline].
|
| 6.
|
Centers for Disease Control and Prevention.
1998.
Summary of notifiable diseases, United States 1997.
Morbid. Mortal. Weekly Rep.
46:1-107.
|
| 7.
|
Chalker, R. B., and M. J. Blaser.
1988.
A review of human salmonellosis. III. Magnitude of Salmonella infection in the United States.
Rev. Infect. Dis.
10:111-124[Medline].
|
| 8.
|
Collazo, C. M., and J. E. Galan.
1997.
The invasion-associated type III system of Salmonella typhimurium directs the translocation of Sip proteins into the host cell.
Mol. Microbiol.
24:747-756[CrossRef][Medline].
|
| 9.
|
Collazo, C. M., and J. E. Galan.
1996.
Requirement for exported proteins in secretion through the invasion-associated type III system of Salmonella typhimurium.
Infect. Immun.
64:3524-3531[Abstract].
|
| 10.
|
Collazo, C. M.,
M. K. Zierler, and J. E. Galán.
1995.
Functional analysis of the Salmonella typhimurium invasion genes invI and invJ and identification of a target of the protein secretion apparatus encoded in the inv locus.
Mol. Microbiol.
15:25-38[Medline].
|
| 11.
|
Fu, Y., and J. E. Galan.
1998.
The Salmonella typhimurium tyrosine phosphatase SptP is translocated into host cells and disrupts the actin cytoskeleton.
Mol. Microbiol.
27:359-368[CrossRef][Medline].
|
| 12.
|
Galyov, E. E.,
M. W. Wood,
R. Rosqvist,
P. B. Mullan,
P. R. Watson,
S. Hedges, and T. S. Wallis.
1997.
A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa.
Mol. Microbiol.
25:903-912[CrossRef][Medline].
|
| 13.
|
Gibson, E. A.
1961.
Salmonellosis in calves.
Vet. Rec.
73:1284-1296.
|
| 14.
|
Glynn, M. K.,
C. Bopp,
W. Dewitt,
P. Dabney,
M. Mokhtar, and F. J. Angulo.
1998.
Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States.
N. Engl. J. Med.
338:1333-1338[Abstract/Free Full Text].
|
| 15.
|
Hardt, W. D., and J. E. Galan.
1997.
A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria.
Proc. Natl. Acad. Sci. USA
94:9887-9892[Abstract/Free Full Text].
|
| 16.
|
Hersh, D.,
D. M. Monack,
M. R. Smith,
N. Ghori,
S. Falkow, and A. Zychlinsky.
1999.
The salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1.
Proc. Natl. Acad. Sci. USA
96:2396-2401[Abstract/Free Full Text].
|
| 17.
|
Hueck, C. J.,
M. J. Hantman,
V. Bajaj,
C. Johnston,
C. A. Lee, and S. I. Miller.
1995.
Salmonella typhimurium secreted invasion determinants are homologous to Shigella Ipa proteins.
Mol. Microbiol.
18:479-490[CrossRef][Medline].
|
| 18.
|
Kaniga, K.,
D. Trollinger, and J. E. Galan.
1995.
Identification of two targets of the type III protein secretion system encoded by the inv and spa loci of Salmonella typhimurium that have homology to the Shigella IpaD and IpaA proteins.
J. Bacteriol.
177:7078-7085[Abstract/Free Full Text].
|
| 19.
|
Kaniga, K.,
S. Tucker,
D. Trollinger, and J. E. Galán.
1995.
Homologs of the Shigella IpaB and IpaC invasins are required for Salmonella typhimurium entry into cultured epithelial cells.
J. Bacteriol.
177:3965-3971[Abstract/Free Full Text].
|
| 20.
|
Khakhria, R.,
D. Woodward,
W. M. Johnson, and C. Poppe.
1997.
Salmonella isolated from humans, animals and other sources in Canada, 1983-92.
Epidemiol. Infect.
119:15-23[CrossRef][Medline].
|
| 21.
|
Kubori, T.,
Y. Matsushima,
D. Nakamura,
J. Uralil,
M. Lara-Tejero,
A. Sukhan,
J. E. Galan, and S. I. Aizawa.
1998.
Supramolecular structure of the Salmonella typhimurium type III protein secretion system.
Science
280:602-605[Abstract/Free Full Text].
|
| 22.
|
Libby, S. J.,
L. G. Adams,
T. A. Ficht,
C. Allen,
H. A. Whitford,
N. A. Buchmeier,
S. Bossie, and D. G. Guiney.
1997.
The spv genes of the Salmonella dublin virulence plasmid are required for severe enteritis and systemic infection in the natural host.
Infect. Immun.
65:1786-1792[Abstract].
|
| 23.
|
Miller, S. I.,
E. L. Hohmann, and D. A. Pegues.
1995.
Salmonella (including Salmonella typhi), p. 2013-2033.
In
G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed., vol. 2. Churchill Livingstone, New York, N.Y.
|
| 24.
|
Norris, F. A.,
M. P. Wilson,
T. S. Wallis,
E. E. Galyov, and P. W. Majerus.
1998.
SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase.
Proc. Natl. Acad. Sci. USA
95:14057-14059[Abstract/Free Full Text].
|
| 25.
|
Pegues, D. A.,
M. J. Hantman,
I. Behlau, and S. I. Miller.
1995.
PhoP/PhoQ transcriptional repression of Salmonella typhimurium invasion genes: evidence for a role in protein secretion.
Mol. Microbiol.
17:169-181[CrossRef][Medline].
|
| 26.
|
Rakeman, J. L.,
H. R. Bonifield, and S. I. Miller.
1999.
A HilA-independent pathway to Salmonella typhimurium invasion gene transcription.
J. Bacteriol.
181:3096-3104[Abstract/Free Full Text].
|
| 27.
|
Rankin, J. D., and R. J. Taylor.
1966.
The estimation of the doses of Salmonella typhimurium for experimental production of disease in calves.
Vet. Rec.
78:706-707[Medline].
|
| 28.
|
Reynolds, D. J.,
J. H. Morgan,
N. Chanter,
P. W. Jones,
J. C. Bridger,
T. G. Debney, and K. J. Bunch.
1986.
Microbiology of calf diarrhoea in southern Britain.
Vet. Rec.
119:34-39[Abstract].
|
| 29.
|
Rothenbacher, H.
1965.
Mortality and morbidity in calves with salmonellosis.
J. Am. Vet. Med. Assoc.
147:1211-1214[Medline].
|
| 30.
|
Saphra, I., and J. W. Winter.
1957.
Clinical manifestations of salmonellosis in man: an evaluation of 7779 human infections identified at the New York Salmonella Center.
N. Engl. J. Med.
256:1128.
|
| 31.
|
Skorupski, K., and R. K. Taylor.
1996.
Positive selection vectors for allelic exchange.
Gene
169:47-52[CrossRef][Medline].
|
| 32.
|
Smith, B. P.,
L. Da Roden,
M. C. Thurmond,
G. W. Dilling,
H. Konrad,
J. A. Pelton, and J. P. Picanso.
1994.
Prevalence of salmonellae in cattle and in the environment on California dairies.
J. Am. Vet. Med. Assoc.
205:467-471[Medline].
|
| 33.
|
Smith, B. P.,
F. Habasha,
M. Reina-Guerra, and A. J. Hardy.
1979.
Bovine salmonellosis: experimental production and characterization of the disease in calves, using oral challenge with Salmonella typhimurium.
Am. J. Vet. Res.
40:1510-1513[Medline].
|
| 34.
|
Sojka, W. J., and H. I. Field.
1970.
Salmonellosis in England and Wales 1958-1967.
Vet. Bull.
40:515-531.
|
| 35.
|
Sojka, W. J.,
C. Wray,
E. B. Hudson, and J. A. Benson.
1975.
Incidence of salmonella infection in animals in England and Wales, 1968-73.
Vet. Rec.
96:280-284.
|
| 36.
|
Stojiljkovic, I.,
A. J. Bäumler, and F. Heffron.
1995.
Ethanolamine utilization in Salmonella typhimurium: nucleotide sequence, protein expression, and mutational analysis of the cchA cchB eutE eutJ eutH gene cluster.
J. Bacteriol.
177:1357-1366[Abstract/Free Full Text].
|
| 37.
|
Threlfall, E. J.,
M. L. Hall, and B. Rowe.
1992.
Salmonella bacteraemia in England and Wales, 1981-1990.
J. Clin. Pathol.
45:34-36[Abstract/Free Full Text].
|
| 38.
|
Tsolis, R. M.,
L. G. Adams,
T. A. Ficht, and A. J. Bäumler.
1999.
Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves.
Infect. Immun.
67:4879-4885[Abstract/Free Full Text].
|
| 39.
|
Tsolis, R. M.,
S. M. Townsend,
E. A. Miao,
S. I. Miller,
T. A. Ficht,
L. G. Adams, and A. J. Bäumler.
1999.
Identification of a putative Salmonella enterica serotype Typhimurium host range factor with homology to IpaH and YopM by signature-tagged mutagenesis.
Infect. Immun.
67:6385-6393[Abstract/Free Full Text].
|
| 40.
|
Watson, P. R.,
E. E. Galyov,
S. M. Paulin,
P. W. Jones, and T. S. Wallis.
1998.
Mutation of invH, but not stn, reduces Salmonella-induced enteritis in cattle.
Infect. Immun.
66:1432-1438[Abstract/Free Full Text].
|
| 41.
|
Wood, M. W.,
M. A. Jones,
P. R. Watson,
S. Hedges,
T. S. Wallis, and E. E. Galyov.
1998.
Identification of a pathogenicity island required for Salmonella enteropathogenicity.
Mol. Microbiol.
29:883-891[CrossRef][Medline].
|
| 42.
|
Wood, M. W.,
R. Rosqvist,
P. B. Mullan,
M. H. Edwards, and E. E. Galyov.
1996.
SopE, a secreted protein of Salmonella dublin, is translocated into the target eukaryotic cell via a sip-dependent mechanism and promotes bacterial entry.
Mol. Microbiol.
22:327-338[CrossRef][Medline].
|
| 43.
|
Wray, C., and W. J. Sojka.
1978.
Experimental Salmonella typhimurium infection in calves.
Res. Vet. Sci.
25:139-143[Medline].
|
| 44.
|
Zhou, D.,
M. S. Mooseker, and J. E. Galán.
1999.
Role of the S. typhimurium actin-binding protein SipA in bacterial internalization.
Science
283:2092-2095[Abstract/Free Full Text].
|
| 45.
|
Zhou, D.,
M. S. Mooseker, and J. E. Galan.
1999.
An invasion-associated Salmonella protein modulates the actin-bundling activity of plastin.
Proc. Natl. Acad. Sci. USA
96:10176-10181[Abstract/Free Full Text].
|
Infection and Immunity, June 2000, p. 3158-3163, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Raffatellu, M., Sun, Y.-H., Wilson, R. P., Tran, Q. T., Chessa, D., Andrews-Polymenis, H. L., Lawhon, S. D., Figueiredo, J. F., Tsolis, R. M., Adams, L. G., Baumler, A. J.
(2005). Host Restriction of Salmonella enterica Serotype Typhi Is Not Caused by Functional Alteration of SipA, SopB, or SopD. Infect. Immun.
73: 7817-7826
[Abstract]
[Full Text]
-
Raffatellu, M., Wilson, R. P., Chessa, D., Andrews-Polymenis, H., Tran, Q. T., Lawhon, S., Khare, S., Adams, L. G., Baumler, A. J.
(2005). SipA, SopA, SopB, SopD, and SopE2 Contribute to Salmonella enterica Serotype Typhimurium Invasion of Epithelial Cells. Infect. Immun.
73: 146-154
[Abstract]
[Full Text]
-
Lilic, M., Galkin, V. E., Orlova, A., VanLoock, M. S., Egelman, E. H., Stebbins, C. E.
(2003). Salmonella SipA Polymerizes Actin by Stapling Filaments with Nonglobular Protein Arms. Science
301: 1918-1921
[Abstract]
[Full Text]
-
Logsdon, L. K., Mecsas, J.
(2003). Requirement of the Yersinia pseudotuberculosis Effectors YopH and YopE in Colonization and Persistence in Intestinal and Lymph Tissues. Infect. Immun.
71: 4595-4607
[Abstract]
[Full Text]
-
Haraga, A., Miller, S. I.
(2003). A Salmonella enterica Serovar Typhimurium Translocated Leucine-Rich Repeat Effector Protein Inhibits NF-{kappa}B-Dependent Gene Expression. Infect. Immun.
71: 4052-4058
[Abstract]
[Full Text]
-
Barthel, M., Hapfelmeier, S., Quintanilla-Martinez, L., Kremer, M., Rohde, M., Hogardt, M., Pfeffer, K., Russmann, H., Hardt, W.-D.
(2003). Pretreatment of Mice with Streptomycin Provides a Salmonella enterica Serovar Typhimurium Colitis Model That Allows Analysis of Both Pathogen and Host. Infect. Immun.
71: 2839-2858
[Abstract]
[Full Text]
-
Zhang, S., Kingsley, R. A., Santos, R. L., Andrews-Polymenis, H., Raffatellu, M., Figueiredo, J., Nunes, J., Tsolis, R. M., Adams, L. G., Baumler, A. J.
(2003). Molecular Pathogenesis of Salmonella enterica Serotype Typhimurium-Induced Diarrhea. Infect. Immun.
71: 1-12
[Full Text]
-
Zhang, S., Santos, R. L., Tsolis, R. M., Stender, S., Hardt, W.-D., Baumler, A. J., Adams, L. G.
(2002). The Salmonella enterica Serotype Typhimurium Effector Proteins SipA, SopA, SopB, SopD, and SopE2 Act in Concert To Induce Diarrhea in Calves. Infect. Immun.
70: 3843-3855
[Abstract]
[Full Text]
-
Santos, R. L., Tsolis, R. M., Baumler, A. J., Smith, R. III, Adams, L. G.
(2001). Salmonella enterica Serovar Typhimurium Induces Cell Death in Bovine Monocyte-Derived Macrophages by Early sipB-Dependent and Delayed sipB-Independent Mechanisms. Infect. Immun.
69: 2293-2301
[Abstract]
[Full Text]
-
Cherayil, B. J., McCormick, B. A., Bosley, J.
(2000). Salmonella enterica Serovar Typhimurium-Dependent Regulation of Inducible Nitric Oxide Synthase Expression in Macrophages by Invasins SipB, SipC, and SipD and Effector SopE2. Infect. Immun.
68: 5567-5574
[Abstract]
[Full Text]